Biggest News Aggregation in the World
📰 Peter Newcomer News

Peter Newcomer News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Peter Newcomer. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Antibody Drugs For COVID-19 Are A Cumbersome Tool Against Surges

Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of the hospital. Thats an urgent but daunting challenge in Michigan, where hospitals are struggling to keep up with a surge in new cases. Monoclonal antibodies can hold the coronavirus in check by mimicking the bodys natural immune defenses. The drugs, produced by Regeneron and Eli Lilly, can keep people with mild to moderate COVID-19 out of the hospital and have emergency author...
United States University Of Wisconsin Leah Lipsich Gretchen Whitmer Richard Harris Richard Harrisapr

COVID-19 Antibody Drugs Are Tough To Deploy In Surges : Shots

Michigan Office of the Governor/AP hide caption toggle caption Michigan Office of the Governor/AP In an update on COVID-19 Wednesday, Michigan Gov. Gretchen Whitmer discussed the states efforts to expand the use of monoclonal antibody therapy to help those diagnosed with COVID-19 avoid hospitalization. Michigan Office of the Governor/AP Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of ...
United States University Of Wisconsin Leah Lipsich Gretchen Whitmer Eli Lilly National Institutes Of Health
Source: npr.org

Slow uptake for promising new COVID-19 treatment in Minnesota

Copy shortlink: More than a month after shipments of a promising new COVID-19 treatment started arriving in Minnesota, most of the doses havent been used even though doctors initially feared demand would far outstrip supply. State health officials say some medical centers have reported a surprising lack of patient interest in the outpatient antibody therapy, which might help people avoid hospitalization, but requires an hourlong infusion. Health systems also have struggl...
United States University Of Wisconsin Christopher Snowbeck Raymund Razonable Andrew Olson Donald Trump

Low Demand For Antibody Drugs Against COVID-19

Low Demand For Antibody Drugs Against COVID-19 Update RequiredTo play audio, update browser or Flash plugin. President Trump boards Marine One for a trip from the White House to Walter Reed National Military Medical Center for COVID-19 treatment in early October. Trump received Regenerons antibody cocktail during his illness. Alex Brandon / AP Federal officials are disappointed to find that the monoclonal antibody drugs theyve shipped across the country arent being used rapidly. T...
Republic Of United States Washington Hospital Moncef Slaoui Princy Kumar Ryan Bariola

Low Demand For Antibody Drugs Against COVID-19 | NPR & Houston Public Media

  / President Trump boards Marine One for a trip from the White House to Walter Reed National Military Medical Center for COVID-19 treatment in early October. Trump received Regenerons antibody cocktail during his illness. // AP, Alex Brandon Federal officials are disappointed to find that the monoclonal antibody drugs theyve shipped across the country arent being used rapidly. These drugs are designed to prevent people recently diagnosed with COVID-19 from ending up in the hospital. But...
Republic Of United States Washington Hospital Moncef Slaoui Princy Kumar Alex Brandon

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science